Inflammation and Atherosclerosis: Prospects for Clinical Trials

TARGETING INNATE IMMUNITY 

CYTOKINES AND CHEMOKINES

COLCHICINE

GLUCOCORTICOIDS, NONSTEROIDAL ANTI-INFLAMMATORY AGENTS, METHOTREXATE

TARGETING ADAPTIVE IMMUNE CELLS

exciting era